Oral NAloxone to overcome the moRphine effect in acute COronary syndrome patients treated with TICagrelor — NARCOTIC trial

BACKGROUND: Numerous worldwide clinical trials have proven the indisputably negative influence of morphine on the pharmacokinetics and pharmacodynamics of P2Y12 receptor inhibitors in patients presenting with acute coronary syndromes. The aim of this trial was to evaluate whether oral coadministrati...

詳細記述

書誌詳細

出版年:	Cardiology Journal
主要な著者:	Piotr Niezgoda, Malwina A. Barańska, Joanna Sikora, Przemysław Sobczak, Katarzyna Buszko, Adam Sikora, Michał P. Marszałł, Eliano P. Navarese, Bernd Jilma, Jacek Kubica
フォーマット:	論文
言語:	英語
出版事項:	Via Medica 2022-05-01
主題:	acute coronary syndrome unstable angina ticagrelor morphine naloxone
オンライン･アクセス:	https://journals.viamedica.pl/cardiology_journal/article/view/65876